Yposkesi (SK Pharmteco)

Corbeil-Essonnes, FR
AAV Lentiviral Plasmid
Program data pending ClinicalTrials.gov matching · Last scored 2026-04-02
80.3
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ✓ EMA GMP (1) ○ MHRA GMP

Quick Facts: Yposkesi (SK Pharmteco)

Signal Score
80.3/100 (as of 2026-04-02)
Quality Compliance
100.0/100 — No FDA inspection records found for this manufacturer
Headquarters
Corbeil-Essonnes, FR
Modalities
AAV, Lentiviral, Plasmid
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

Signal Score & Pillar Breakdown

Quality Compliance 100.0
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Source: FDA Data Dashboard
No FDA inspection records found for this manufacturer · Quality score requires FDA inspection data
FDA InspectionsNo US records on file
EMA GMP Certificates1 on record
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesAAV, Lentiviral, Plasmid
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 68.0
Parent company: SK Pharmteco
Financial assessment: 68.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: SK Pharmteco
Financial assessment: 68.0/100
Capacity 58.0
1 manufacturing site: Corbeil-Essonnes, FR
Modalities: AAV, Lentiviral, Plasmid
Capacity assessment: 58.0/100
Sites: Corbeil-Essonnes, FR
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
1 manufacturing site: Corbeil-Essonnes, FR
Modalities: AAV, Lentiviral, Plasmid
Capacity assessment: 58.0/100

EMA GMP Compliance 1 certificates

2022-04
Compliant Non-Compliant
Certificate Site Country Inspection Date Status
2022_HPF_FR_143_1_P_2025 YposKesi France 2022-04-08 COMPLIANT
Source: EMA EudraGMDP · Retrieved Apr 05, 2026
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
AAV CDMOs → Lentiviral CDMOs → Plasmid CDMOs →

Similar CDMOs

Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 92.2
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 88.0
AAV, Lentiviral, Plasmid, mRNA
Pharmaron Biologics
San Diego, CA · Shaoxing, CN
Signal Score: 85.6
AAV, Lentiviral, Plasmid
Catalent (Novo Holdings)
Harmans, MD · Gosselies, BE
Signal Score: 79.7
AAV, CAR-T, Lentiviral, Plasmid
Ascend Advanced Therapies
Philadelphia, PA
Signal Score: 78.1
AAV, Lentiviral, Plasmid